Literature DB >> 28275263

Systemic sclerosis: Antifibrotic effects of PDE4 blockade?

Sarah Onuora.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28275263     DOI： 10.1038/nrrheum.2017.34

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

1.  Inhibition of phosphodiesterase 4 (PDE4) reduces dermal fibrosis by interfering with the release of interleukin-6 from M2 macrophages.

Authors:  Christiane Maier; Andreas Ramming; Christina Bergmann; Rita Weinkam; Nicolai Kittan; Georg Schett; Jörg H W Distler; Christian Beyer
Journal:  Ann Rheum Dis       Date:  2017-02-16       Impact factor: 19.103
  1 in total
  1 in total

1.  Inhibition of PDE4 by apremilast attenuates skin fibrosis through directly suppressing activation of M1 and T cells.

Authors:  Qiu-Kai Lu; Chen Fan; Cai-Gui Xiang; Bing Wu; Hui-Min Lu; Chun-Lan Feng; Xiao-Qian Yang; Heng Li; Wei Tang
Journal:  Acta Pharmacol Sin       Date:  2021-04-13       Impact factor: 7.169
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.